SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Evoqua Water Technologies Corp. – ‘8-K’ for 1/7/20 – ‘EX-99.2’

On:  Tuesday, 1/7/20, at 4:58pm ET   ·   For:  1/7/20   ·   Accession #:  1604643-20-3   ·   File #:  1-38272

Previous ‘8-K’:  ‘8-K’ on / for 12/20/19   ·   Next:  ‘8-K’ on / for 2/4/20   ·   Latest:  ‘8-K’ on / for 5/24/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 1/07/20  Evoqua Water Technologies Corp.   8-K:2,7,9   1/07/20    3:250K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     23K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      8K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     79K 


‘EX-99.2’   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 99.2
UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS
On December 31, 2019, Evoqua Water Technologies Corp. (the “Company”), through its wholly-owned subsidiaries, completed the previously-announced sale (the “Transaction”) of the Company’s Memcor® low pressure membrane product line (including the product line’s global workforce, its manufacturing site in Windsor, Australia, associated operations and intellectual property) to DuPont de Nemours, Inc. and its affiliates (collectively, “DuPont”) pursuant to the Purchase and Sale Agreement dated October 1, 2019, by and among the Evoqua Sellers and DuPont, as amended (the “Agreement”). DuPont purchased 100% of the corporate capital of the Australian Subsidiaries and all of the other Evoqua Sellers’ assets related to the Memcor® low pressure membrane product line. The aggregate purchase price paid by DuPont in the Transaction was $110.0 million in cash, subject to certain adjustments. Following adjustments for cash and net working capital, gross proceeds paid by DuPont were $121.3 million, with an expected gain on the divestiture of $70.9 million. The Company and DuPont have a history of collaboration, and following the closing of the Transaction, DuPont will continue to supply the Company with Memcor® products.
The Transaction constituted a significant business divestiture in accordance with Rule 3-05 of Regulation S-X. As a result, we prepared the accompanying unaudited pro forma combined financial statements in accordance with Item 9.01(b) of Form 8-K and Article 11 of Regulation S-X.
The unaudited pro forma combined Balance Sheets and Statements of Operations were prepared as though the divestiture occurred on October 1, 2018. The historical financial statements have been recast for periods required under ASC 205-20, and have been adjusted in the unaudited pro forma combined financial statements to give effect to pro forma events that are: (1) directly attributable to the divestiture, (2) factually supportable, and (3) with respect to the unaudited pro forma combined statements of operations, expected to have a continuing impact on the combined results following the divestiture. In addition, these unaudited pro forma combined financial statements should not be considered to be indicative of our future consolidated financial performance and income statement results.
The unaudited pro forma combined financial statements have been developed from, and should be read in conjunction with, our historical audited consolidated financial statements and accompanying notes contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019.


1



Evoqua Water Technologies Corp.
Proforma Combined Balance Sheet
As of September 30, 2019
(Unaudited)
(In thousands)
Evoqua Water Technologies Corp.
 
Memcor (note 2)
 
ProForma Adjustments
 
Pro Forma Combined
ASSETS
 
 
 
 
 
 
 
Current assets
$
637,293

 
$
84,093


$

 
$
721,386

Cash and cash equivalents
109,881

 
121,349

 

 
231,230

Receivables, net
257,585

 

 

 
257,585

Inventories, net
137,164

 

 

 
137,164

Contract assets
73,467

 

 

 
73,467

Prepaid and other current assets
21,940

 

 

 
21,940

Assets held for sale
37,256

 
(37,256
)
 

 

Property, plant, and equipment, net
333,584

 

 

 
333,584

Goodwill
392,890

 

 

 
392,890

Intangible assets, net
314,767

 

 

 
314,767

Deferred income taxes
2,790

 
174

 

 
2,964

Other non‑current assets
25,715

 

 

 
25,715

Non-current assets held for sale
30,809

 
(30,809
)
 

 

Total assets
$
1,737,848


$
53,458

 
$

 
$
1,791,306

LIABILITIES AND EQUITY
 
 
 
 
 
 

Current liabilities
322,221

 
(14,085
)
 
(2,601
)
 
305,535

Accounts payable
144,247

 

 

 
144,247

Current portion of debt
13,418

 

 

 
13,418

Contract liabilities
39,051

 

 

 
39,051

Product warranties
4,922

 

 

 
4,922

Accrued expenses and other liabilities
101,839

 

 
(2,601
)
4
99,238

Income tax payable
4,536

 
123

 


 
4,659

Liabilities held for sale
14,208

 
(14,208
)
 

 

Non‑current liabilities
1,049,805

 
(7,059
)
 

 
1,042,746

Long‑term debt
951,599

 

 

 
951,599

Product warranties
2,332

 

 

 
2,332

Other non‑current liabilities
78,661

 

 

 
78,661

Deferred income taxes
13,548

 
(3,394
)
 

 
10,154

Non-current liabilities held for sale
3,665

 
(3,665
)
 

 

Total liabilities
1,372,026

 
(21,144
)
 
(2,601
)
 
1,348,281

Commitments and Contingent Liabilities
 
 
 
 
 
 

Shareholders’ equity
 
 
 
 
 
 

Common stock, par value $0.01: authorized 1,000,000 shares; issued 116,008 shares, outstanding 114,344 at September 30, 2019;
1,154

 

 

 
1,154

Treasury stock: 1,664 shares at September 30, 2019
(2,837
)
 

 

 
(2,837
)
Additional paid‑in capital
552,422

 

 

 
552,422

Retained deficit
(174,976
)
 
68,296

 
2,601

5
(104,079
)
Accumulated other comprehensive loss, net of tax
(13,004
)
 
6,306

 

 
(6,698
)
Total Evoqua Water Technologies Corp. equity
362,759

 
74,602

 
2,601

 
439,962

Non‑controlling interest
3,063

 

 

 
3,063

Total shareholders’ equity
365,822

 
74,602

 
2,601

 
443,025

Total liabilities and shareholders’ equity
$
1,737,848

 
$
53,458

 
$

 
$
1,791,306

See accompanying notes to the unaudited pro forma combined financial statements.

2



Evoqua Water Technologies Corp.
Pro Forma Combined Statements of Operations
Year Ended September 30, 2019
(unaudited)
(In thousands, except per share data)
Evoqua Water Technologies Corp.
for the Year Ended September 30, 2019
 
Historical Memcor for the Year Ended September 30, 2019
 
ProForma Adjustments
 
Pro Forma Combined
Revenue from product sales
$
851,161

 
$
(58,774
)
 
$

 
$
792,387

Revenue from services
593,280

 
(769
)
 

 
592,511

Revenue
1,444,441

 
(59,543
)



1,384,898

Cost of product sales
(615,171
)
 
43,496

 
9

4
(571,666
)
Cost of services
(403,308
)
 
375

 

 
(402,933
)
Cost of product sales and services
(1,018,479
)
 
43,871


9


(974,599
)
Gross Profit
425,962

 
(15,672
)

9


410,299

General and administrative expense
(217,013
)
 
1,135

 
4,233

4
(211,641
)
Sales and marketing expense
(138,936
)
 
6,634

 

 
(132,302
)
Research and development expense
(15,300
)
 
2,294

 

 
(13,006
)
Total operating expenses
(371,249
)
 
10,063


4,233

 
(356,949
)
Other operating income
5,613

 
(162
)
 
70,898

 
76,349

Other operating expense
(654
)
 

 

 
(654
)
Income before interest expense and income taxes
59,672

 
(5,771
)

75,140


129,045

Interest expense
(58,556
)
 

 

 
(58,556
)
Income before income taxes
1,116

 
(5,771
)

75,140


70,489

Income tax expense
(9,587
)
 
4,611

 

3
(4,976
)
Net income
(8,471
)
 
(1,160
)

75,140

 
65,509

Net income attributable to non-controlling interest
1,052

 

 

 
1,052

Net income attributable to Evoqua Water Technologies Corp.
$
(9,523
)
 
$
(1,160
)

$
75,140

 
$
64,457

Basic earnings per common share
$
(0.08
)
 
 
 
 
 
$
0.56

Diluted earnings per common share
$
(0.08
)
 
 
 
 
 
$
0.56

Weighted-average shares used in computation of earnings per share
 
 
 
 
 
 
 
Basic
114,703

 
 
 
 
 
114,703

Diluted
114,703

 
 
 
 
 
114,703

See accompanying notes to the unaudited pro forma combined financial statements.


3



Evoqua Water Technologies Corp.
Notes to the Pro Forma Combined Financial Statements
(Unaudited, in thousands)
Note 1 - Basis of Presentation
The unaudited pro forma combined financial statements were derived from the historical audited consolidated financial statements of Evoqua Water Technologies Corp. (the “Company”) and the unaudited results and balances of the Memcor business. The unaudited pro forma combined financial statements give effect to the pro forma adjustments necessary to reflect the Memcor disposition as if the transaction had occurred on October 1, 2018, in the unaudited pro forma combined balance sheets and statements of operations for the fiscal year ended September 30, 2019.
The historical financial information has been adjusted in the unaudited pro forma combined financial statements to give effect to pro forma events that are (i) directly attributable to the divestiture, (ii) factually supportable and (iii) with respect to the unaudited pro forma combined statements of operations, expected to have a continuing impact on the combined results and have been prepared in accordance with Article 11 of Regulation S-X. Such unaudited pro forma condensed consolidated financial statements should be read in conjunction with (i) the audited consolidated financial statements and accompanying notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the year ended September 30, 2019 included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2019 and (ii) the risk factors outlined in detail under the caption “Risk Factors” within the Reports described above. These reports may not be useful in predicting the future financial condition and results of operations of the Company. The actual results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors.
Note 2 - Memcor Balances
The information in the Memcor column of the unaudited pro forma consolidated balance sheet was derived from the Company’s audited financial statements as of September 30, 2019, adjusted to include certain assets and liabilities that are directly attributable to the Memcor business and have been adjusted in the unaudited pro forma combined financial statements to give effect to pro forma events that are: (1) directly attributable to the divestiture, (2) factually supportable, and (3) with respect to the unaudited pro forma combined statements of operations, expected to have a continuing impact on the combined results following the divestiture. The Memcor column also reflects the $121.3 million cash proceeds received in conjunction with the sale of the Memcor business.
Note 3 - Taxes
Represents the tax impact of the divestiture of the Memcor business. Based on the structure of the sale, available net operating losses, and valuation allowances, the Company does not expect to incur net tax expense related to the gain on the sale of the Memcor business.
Note 4 - Transaction expenses and income
These are one time transaction costs the Company incurred specific to the sale of the Memcor business. As of September 30, 2019, $2.8 million of these costs were incurred but $2.6 million had not been paid and as such, was included in Accrued expenses and other liabilities. The Company expects to incur and pay approximately $1.4 million of additional one time transaction costs subsequent to September 30, 2019.
Note 5 - Shareholder’s equity
Shareholders’ equity was adjusted for the pro forma adjustments specified in Notes (3) and (4), including the $121.3 million cash proceeds received in conjunction with the sale of Memcor. Note that the cash proceeds are subject to post closing net working capital adjustments, and as such, may be subject to change and impact the final gain on sale.




4

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:1/7/20
12/31/19
10/1/19
9/30/1910-K,  10-K/A
10/1/18
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/10/21  Evoqua Water Technologies Corp.   424B3                  1:483K                                   Toppan Merrill/FA
12/03/20  Evoqua Water Technologies Corp.   424B3                  1:343K                                   Toppan Merrill-FA
12/01/20  Evoqua Water Technologies Corp.   424B3                  1:338K                                   Toppan Merrill-FA
 8/07/20  Evoqua Water Technologies Corp.   424B3       8/07/20    1:346K                                   Toppan Merrill-FA
 8/06/20  Evoqua Water Technologies Corp.   424B3                  1:342K                                   Toppan Merrill-FA
Top
Filing Submission 0001604643-20-000003   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 10:48:40.1am ET